Peptide questions · Liraglutide
Liraglutide side effects: what studies and users report
Reviewed Evidence: EstablishedPublished by PepVault
The side effects most commonly reported for liraglutide are nausea, vomiting and diarrhea, among 6 the library lists; the library’s evidence on it includes controlled trials in people.
The library holds no separate safety note for liraglutide.
What is commonly reported with liraglutide
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Pancreatitis risk
- Thyroid C-cell tumor risk (animal data)
Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.
| Effect | Also listed for (of 24) |
|---|---|
| Nausea | 21: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 17 more |
| Vomiting | 18: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 14 more |
| Diarrhea | 20: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 16 more |
| Constipation | 13: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 9 more |
| Pancreatitis risk | 1: Semaglutide |
| Thyroid C-cell tumor risk (animal data) | None: listed for Liraglutide alone |

Model. Individual results vary.
Which liraglutide side effects the metabolic & GLP-1 group shares
Across the 25 metabolic & GLP-1 compounds in the library, the effects listed most often are nausea (22 of 25), diarrhea (21 of 25), vomiting (19 of 25) and constipation (14 of 25). Liraglutide shares 5 of its 6 listed effects with at least one other metabolic & GLP-1 compound; thyroid C-cell tumor risk (animal data) is listed for liraglutide alone.
What the liraglutide safety notes say
The library’s interaction note
The Saxenda label advises against combining it with other liraglutide products or any other GLP-1 drug.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Where the liraglutide reports come from
The library rates the evidence on liraglutide as established: clinical trials or FDA-approved use exist.
Of the library’s 5 research notes on liraglutide, 5 rest on randomized trials.
Our 4 study pages on liraglutide: 4 randomized trials.
So liraglutide has controlled trials in people to set its listed effects against.
What our liraglutide study pages report on safety
Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8
Randomized trial, human, 2022: Stomach and gut side effects were about as common in both arms: 82.7% with liraglutide and 84.1% with semaglutide. In this head-to-head trial, daily liraglutide led to less weight loss than weekly semaglutide over 68 weeks, and more people stopped taking it, while gut side effects were similar for both.
Liraglutide: 8.4 kg lost vs 2.8 kg on placebo at 56 weeks
Randomized trial, human, 2015: Nausea and diarrhea, mostly mild or moderate, were the most common side effects, and serious events occurred in 6.2% of the liraglutide group versus 5.0% of the placebo group. In a large placebo-controlled trial, liraglutide 3.0 mg with lifestyle counseling led to more weight loss than counseling alone, with stomach side effects as the most common issue.
Questions people ask
What are the side effects of liraglutide?
The side effects most commonly reported for liraglutide are nausea, vomiting and diarrhea, among 6 the library lists; the library’s evidence on it includes controlled trials in people.
Do liraglutide’s side effects come from human studies?
The library rates the evidence on liraglutide as established, and the library’s evidence on it includes controlled trials in people.
Which liraglutide side effects are its own?
Among the metabolic & GLP-1 compounds, the library lists thyroid C-cell tumor risk (animal data) for liraglutide alone.
Does liraglutide interact with other medicines?
The library’s interaction note on liraglutide begins: The Saxenda label advises against combining it with other liraglutide products or any other GLP-1 drug.